Experimental drug offers hope for tough blood cancers
NCT ID NCT06618001
Summary
This early-stage study is testing a new drug called JNJ-89853413 for adults with acute myeloid leukemia or myelodysplastic neoplasms that have returned or stopped responding to previous treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also check if the drug helps control these blood cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, MYELOID, ACUTE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Addenbrookes Hospital
RECRUITINGCambridge, Cb2 2qq, United Kingdom
-
Arthur J E Child Comprehensive Cancer Centre
RECRUITINGCalgary, Alberta, T2N 5G2, Canada
-
Clinica Univ. de Navarra
RECRUITINGPamplona, 31008, Spain
-
Hosp Clinic de Barcelona
RECRUITINGBarcelona, 08036, Spain
-
Hosp Univ Fund Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
-
Princess Margaret Hospital
RECRUITINGToronto, Ontario, M5G 2C1, Canada
-
The Christie NHS Foundation Trust Christie Hospital
RECRUITINGManchester, M20 4BX, United Kingdom
-
University College London Hospitals
RECRUITINGLondon, W1T 7HA, United Kingdom
-
Vancouver General Hospital
RECRUITINGVancouver, British Columbia, V5Z 1M9, Canada
Conditions
Explore the condition pages connected to this study.